Epitizide

DB13989

small molecule experimental

Deskripsi

Epitizide is an agent, commonly found in combination triamterene, used to produce diuresis.

Struktur Molekul 2D

Berat 425.84
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

1095 Data
Allopurinol The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Epitizide.
Carbamazepine The risk or severity of adverse effects can be increased when Epitizide is combined with Carbamazepine.
Cyclophosphamide The risk or severity of granulocytopenia can be increased when Epitizide is combined with Cyclophosphamide.
Diazoxide The risk or severity of hypotension, hyperglycemia, and hyperuricemia can be increased when Epitizide is combined with Diazoxide.
Dofetilide The risk or severity of QTc prolongation can be increased when Epitizide is combined with Dofetilide.
Ivabradine The risk or severity of Cardiac Arrhythmia can be increased when Epitizide is combined with Ivabradine.
Lithium citrate Epitizide may decrease the excretion rate of Lithium citrate which could result in a higher serum level.
Lithium carbonate Epitizide may decrease the excretion rate of Lithium carbonate which could result in a higher serum level.
Lithium hydroxide Epitizide may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level.
Oxcarbazepine The risk or severity of hyponatremia can be increased when Epitizide is combined with Oxcarbazepine.
Topiramate The risk or severity of hypokalemia can be increased when Epitizide is combined with Topiramate.
Toremifene The risk or severity of hypercalcemia can be increased when Epitizide is combined with Toremifene.
Sulpiride The risk or severity of orthostatic hypotension can be increased when Epitizide is combined with Sulpiride.
Insulin human The therapeutic efficacy of Insulin human can be decreased when used in combination with Epitizide.
Insulin lispro The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Epitizide.
Insulin glargine The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Epitizide.
Insulin pork The therapeutic efficacy of Insulin pork can be decreased when used in combination with Epitizide.
Troglitazone The therapeutic efficacy of Troglitazone can be decreased when used in combination with Epitizide.
Glimepiride The therapeutic efficacy of Glimepiride can be decreased when used in combination with Epitizide.
Sulfisoxazole The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Epitizide.
Disopyramide The therapeutic efficacy of Disopyramide can be decreased when used in combination with Epitizide.
Acarbose The therapeutic efficacy of Acarbose can be decreased when used in combination with Epitizide.
Metformin The therapeutic efficacy of Metformin can be decreased when used in combination with Epitizide.
Sulfadiazine The therapeutic efficacy of Sulfadiazine can be decreased when used in combination with Epitizide.
Rosiglitazone The therapeutic efficacy of Rosiglitazone can be decreased when used in combination with Epitizide.
Acetohexamide The therapeutic efficacy of Acetohexamide can be decreased when used in combination with Epitizide.
Quinine The therapeutic efficacy of Quinine can be decreased when used in combination with Epitizide.
Miglitol The therapeutic efficacy of Miglitol can be decreased when used in combination with Epitizide.
Chlorpropamide The therapeutic efficacy of Chlorpropamide can be decreased when used in combination with Epitizide.
Nateglinide The therapeutic efficacy of Nateglinide can be decreased when used in combination with Epitizide.
Pentamidine The therapeutic efficacy of Pentamidine can be decreased when used in combination with Epitizide.
Mifepristone The therapeutic efficacy of Mifepristone can be decreased when used in combination with Epitizide.
Tolazamide The therapeutic efficacy of Tolazamide can be decreased when used in combination with Epitizide.
Repaglinide The therapeutic efficacy of Repaglinide can be decreased when used in combination with Epitizide.
Phenformin The therapeutic efficacy of Phenformin can be decreased when used in combination with Epitizide.
Sulfamethoxazole The therapeutic efficacy of Sulfamethoxazole can be decreased when used in combination with Epitizide.
Glyburide The therapeutic efficacy of Glyburide can be decreased when used in combination with Epitizide.
Glipizide The therapeutic efficacy of Glipizide can be decreased when used in combination with Epitizide.
Gliclazide The therapeutic efficacy of Gliclazide can be decreased when used in combination with Epitizide.
Tolbutamide The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Epitizide.
Pioglitazone The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Epitizide.
Bromocriptine The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Epitizide.
Gliquidone The therapeutic efficacy of Gliquidone can be decreased when used in combination with Epitizide.
Mitiglinide The therapeutic efficacy of Mitiglinide can be decreased when used in combination with Epitizide.
Sitagliptin The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Epitizide.
Sunitinib The therapeutic efficacy of Sunitinib can be decreased when used in combination with Epitizide.
Exenatide The therapeutic efficacy of Exenatide can be decreased when used in combination with Epitizide.
Mecasermin The therapeutic efficacy of Mecasermin can be decreased when used in combination with Epitizide.
Pramlintide The therapeutic efficacy of Pramlintide can be decreased when used in combination with Epitizide.
Glisoxepide The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Epitizide.
Insulin aspart The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Epitizide.
Insulin detemir The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Epitizide.
Insulin glulisine The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Epitizide.
Glymidine The therapeutic efficacy of Glymidine can be decreased when used in combination with Epitizide.
AICA ribonucleotide The therapeutic efficacy of AICA ribonucleotide can be decreased when used in combination with Epitizide.
Buformin The therapeutic efficacy of Buformin can be decreased when used in combination with Epitizide.
Vildagliptin The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Epitizide.
Voglibose The therapeutic efficacy of Voglibose can be decreased when used in combination with Epitizide.
NN344 The therapeutic efficacy of NN344 can be decreased when used in combination with Epitizide.
AMG-222 The therapeutic efficacy of AMG-222 can be decreased when used in combination with Epitizide.
Bisegliptin The therapeutic efficacy of Bisegliptin can be decreased when used in combination with Epitizide.
Alogliptin The therapeutic efficacy of Alogliptin can be decreased when used in combination with Epitizide.
Dapagliflozin The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Epitizide.
Saxagliptin The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Epitizide.
Liraglutide The therapeutic efficacy of Liraglutide can be decreased when used in combination with Epitizide.
Gosogliptin The therapeutic efficacy of Gosogliptin can be decreased when used in combination with Epitizide.
Linagliptin The therapeutic efficacy of Linagliptin can be decreased when used in combination with Epitizide.
Canagliflozin The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Epitizide.
Glibornuride The therapeutic efficacy of Glibornuride can be decreased when used in combination with Epitizide.
Benfluorex The therapeutic efficacy of Benfluorex can be decreased when used in combination with Epitizide.
Albiglutide The therapeutic efficacy of Albiglutide can be decreased when used in combination with Epitizide.
Dulaglutide The therapeutic efficacy of Dulaglutide can be decreased when used in combination with Epitizide.
Lobeglitazone The therapeutic efficacy of Lobeglitazone can be decreased when used in combination with Epitizide.
Netoglitazone The therapeutic efficacy of Netoglitazone can be decreased when used in combination with Epitizide.
Rivoglitazone The therapeutic efficacy of Rivoglitazone can be decreased when used in combination with Epitizide.
Ciglitazone The therapeutic efficacy of Ciglitazone can be decreased when used in combination with Epitizide.
Lixisenatide The therapeutic efficacy of Lixisenatide can be decreased when used in combination with Epitizide.
Insulin beef The therapeutic efficacy of Insulin beef can be decreased when used in combination with Epitizide.
Insulin degludec The therapeutic efficacy of Insulin degludec can be decreased when used in combination with Epitizide.
Insulin peglispro The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with Epitizide.
Insulin tregopil The therapeutic efficacy of Insulin tregopil can be decreased when used in combination with Epitizide.
Ipragliflozin The therapeutic efficacy of Ipragliflozin can be decreased when used in combination with Epitizide.
Dutogliptin The therapeutic efficacy of Dutogliptin can be decreased when used in combination with Epitizide.
Allicin The therapeutic efficacy of Allicin can be decreased when used in combination with Epitizide.
Tofogliflozin The therapeutic efficacy of Tofogliflozin can be decreased when used in combination with Epitizide.
Ertugliflozin The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Epitizide.
2,4-thiazolidinedione The therapeutic efficacy of 2,4-thiazolidinedione can be decreased when used in combination with Epitizide.
Teneligliptin The therapeutic efficacy of Teneligliptin can be decreased when used in combination with Epitizide.
Omarigliptin The therapeutic efficacy of Omarigliptin can be decreased when used in combination with Epitizide.
Carmegliptin The therapeutic efficacy of Carmegliptin can be decreased when used in combination with Epitizide.
Gemigliptin The therapeutic efficacy of Gemigliptin can be decreased when used in combination with Epitizide.
Anagliptin The therapeutic efficacy of Anagliptin can be decreased when used in combination with Epitizide.
Evogliptin The therapeutic efficacy of Evogliptin can be decreased when used in combination with Epitizide.
Sotagliflozin The therapeutic efficacy of Sotagliflozin can be decreased when used in combination with Epitizide.
Balaglitazone The therapeutic efficacy of Balaglitazone can be decreased when used in combination with Epitizide.
Remogliflozin etabonate The therapeutic efficacy of Remogliflozin etabonate can be decreased when used in combination with Epitizide.
Carbutamide The therapeutic efficacy of Carbutamide can be decreased when used in combination with Epitizide.
Guar gum The therapeutic efficacy of Guar gum can be decreased when used in combination with Epitizide.
Metahexamide The therapeutic efficacy of Metahexamide can be decreased when used in combination with Epitizide.
Semaglutide The therapeutic efficacy of Semaglutide can be decreased when used in combination with Epitizide.

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul